VALIANT LABORATORIES LTD Financial Ratios
VALIANTLAB · Healthcare · Current price ₹63.44
P/E ratio
—
P/B ratio
1.1x
ROE
-1.2%
ROCE
1.0%
Debt / Equity
0.15
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | — | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -1.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 1.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.15 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with VALIANT LABORATORIES LTD's latest numbers.
VALIANT LABORATORIES LTD profitability
VALIANT LABORATORIES LTD generates a return on equity of -1.2% and a return on capital employed of 1.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.15 and a P/E of —, VALIANT LABORATORIES LTD is conservatively financed. Our overall business-quality score for the company is 2.9 / 10.
Understand the ratios
More on VALIANT LABORATORIES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.